Abstract
This article provides a summary of some of the most current research on the delivery of drugs to the lungs, as well as a discussion of some of the limitations of these studies. Nebulizers have been in use for more than a century to deliver aerosolized drugs to patients suffering from respiratory disorders. Aerosol devices such as these are the best option for people who have trouble managing their inhalation. Because of the actuation required, pressurised Metered-Dose Inhalers (pMDI) and Dry Powder Inhalers (DPI) are unable to generate the necessary inspiratory flow required for successful aerosol drug delivery. Currently, we are looking into how the working mechanism of different nebulizers interacts with the physicochemical features of the formulations. We are looking into a wide range of devices, such as jet, ultrasonic, and vibrating-mesh nebulizers. In this study, the researchers hope to describe the many different types of nebulizers that are currently available on the market, evaluate their performance in aerosol drug delivery, and recommend treatment approaches for patients with chronic obstructive pulmonary disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
